HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenosine and opioid receptors do not trigger the cardioprotective effect of mild hypothermia.

Abstract
Mild hypothermia (32°C-34°C) exerts a potent cardioprotection in animal models of myocardial infarction. Recently, it has been proposed that this beneficial effect is related to survival signaling. We, therefore, hypothesized that the well-known cardioprotective pathways dependent on adenosine and/or opioid receptors could be the trigger of hypothermia-induced salvage. Open-chest rabbits were accordingly exposed to 30 minutes of coronary artery occlusion (CAO) under normothermic (NT) or hypothermic ([HT] 32°C) conditions. In the latter, hypothermia was induced by total liquid ventilation with temperature-controlled perfluorocarbons in order to effect ultrafast cooling and to accurately control cardiac temperature. After 4 hours of reperfusion, infarct and no-reflow zone sizes were assessed and quantified as a percentage of the risk zone. In animals experiencing HT ischemia, the infarct size was dramatically reduced as compared to NT animals (9% ± 3% vs 55% ± 2% of the risk zone, respectively). Importantly, administration of opioid and adenosine receptor antagonists (naloxone [6 mg/kg iv] and 8-(p-sulfophenyl) theophylline [20 mg/kg iv], respectively) did not alter the infarct size or affect the cardioprotective effect of hypothermia. Doses of these 2 antagonists were appropriately chosen since they blunted infarct size reduction induced by selective opioid or adenosine receptor stimulation with morphine (0.3 mg/kg iv) or N (6)-cyclopentyladenosine ([CPA] 100 μg/kg iv), respectively. Therefore, the cardioprotective effect of mild hypothermia is not triggered by either opioid or adenosine receptor activation, suggesting the involvement of other cardioprotective pathways.
AuthorsLys Darbera, Mourad Chenoune, Fanny Lidouren, Bijan Ghaleh, Michael V Cohen, James M Downey, Alain Berdeaux, Renaud Tissier
JournalJournal of cardiovascular pharmacology and therapeutics (J Cardiovasc Pharmacol Ther) Vol. 17 Issue 2 Pg. 173-80 (Jun 2012) ISSN: 1940-4034 [Electronic] United States
PMID21725026 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Opioid
  • Fluorocarbons
  • Narcotic Antagonists
  • Purinergic P1 Receptor Antagonists
  • Receptors, Opioid
  • Receptors, Purinergic P1
  • Naloxone
  • N(6)-cyclopentyladenosine
  • Morphine
  • 8-(4-sulfophenyl)theophylline
  • Theophylline
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, pharmacology)
  • Analgesics, Opioid (pharmacology)
  • Animals
  • Fluorocarbons (chemistry)
  • Hypothermia, Induced (methods)
  • Morphine (pharmacology)
  • Myocardial Infarction (physiopathology, therapy)
  • Naloxone (pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Purinergic P1 Receptor Antagonists (pharmacology)
  • Rabbits
  • Receptors, Opioid (drug effects, metabolism)
  • Receptors, Purinergic P1 (drug effects, metabolism)
  • Theophylline (analogs & derivatives, pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: